All GLP-1 pathway compounds carry the class boxed warning for thyroid C-cell tumor risk
BAs act in the brain by interacting with key receptors on neurons and glial cells-Farnesoid X receptor (FXR), Takeda G protein receptor 5 (TGR5), GR, and sphingosine-1-phosphate receptor 2 (S1PR2
doi: 10.1210/en.2011-0174 190 HayesMRDe JongheBCKanoskiSE
The master suit names several GLP-1 drugs, including Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, and Trulicity
2017), and enhance muscular strength and exercise endurance (Hirohiko et al
In November 2023, a version of the drug was approved for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition